CFTR and cystic fibrosis: Finally, combination of the CFTR modulators and correctors Elexacaftor-Tezacaftor-Ivacaftor, recently approved by FDA (Trikafta) and EMA (Kaftrio) is a game-changer for the treatment of CF.